🇫🇷 SAN.PA — Sanofi

Healthcare Compra
← Volver

Precio actual

76,26 EUR

Máx. histórico

110,88

543 días

Caída desde máximo

-31,22%

Rango 52 semanas

71,25 – 91,15

Variación hoy

-0,01%

Cierre anterior

76,27

Rango de hoy

75,90 – 76,65

Volumen hoy

1.490.914

Información
Nombre completo
Sanofi
Divisa
EUR
Mercado
Paris
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
74.846
PER ⓘ
23,54 (puede no estar actualizado)
Dividend yield
5,40% (puede no estar actualizado)
Precio objetivo analistas
94,28 EUR (puede no estar actualizado)
Primera cotización
03/01/2000
Precio actualizado
hace 2 días
Sobre la empresa

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

Dividendos repartidos Total últimos 12 meses: 4,1200 EUR · Yield: 5,40%
Fecha de pago Importe por participación
16/05/2011 2,5000 EUR
20/05/2010 2,4000 EUR
23/04/2009 2,2000 EUR
16/05/2008 2,0700 EUR
07/06/2007 1,7500 EUR
29/11/2006 0,2668 EUR
07/06/2006 1,5200 EUR
29/11/2005 0,2409 EUR
07/06/2005 1,2000 EUR
30/09/2004 0,0750 EUR
05/05/2004 1,4550 EUR
02/06/2003 0,8400 EUR
03/06/2002 0,6600 EUR
01/06/2001 0,4400 EUR
05/06/2000 0,3200 EUR
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
17/09/2018 74,90 75,13 74,54 74,69 -0,70% 0,78% 1.574.550
14/09/2018 75,33 75,41 74,78 75,22 -0,07% 0,83% 1.914.006
13/09/2018 74,34 75,42 74,29 75,27 +1,43% 1,51% 2.651.464
12/09/2018 73,10 74,30 73,05 74,20 +1,83% 1,71% 2.510.557
11/09/2018 73,19 73,19 72,55 72,87 -0,30% 0,87% 1.794.590
10/09/2018 73,30 73,60 72,93 73,09 +0,71% 0,91% 2.259.145
07/09/2018 71,91 72,57 71,84 72,57 +0,97% 1,02% 1.980.683
06/09/2018 71,96 72,42 71,86 71,88 -0,39% 0,79% 2.066.193
05/09/2018 72,68 72,76 71,96 72,16 -0,82% 1,11% 2.665.908
04/09/2018 74,10 74,16 72,66 72,75 -1,81% 2,03% 2.165.486
03/09/2018 73,40 74,35 73,35 74,10 +0,69% 1,37% 1.499.887
31/08/2018 74,20 74,28 73,32 73,59 -0,79% 1,30% 556.038
30/08/2018 74,57 74,57 73,76 74,17 -0,48% 1,09% 1.851.634
29/08/2018 74,14 74,62 74,06 74,53 +0,81% 0,76% 1.407.202
28/08/2018 74,10 74,20 73,56 73,94 -0,38% 0,87% 1.776.272
27/08/2018 74,65 74,78 73,97 74,21 -0,11% 1,09% 1.173.127
24/08/2018 74,31 74,49 74,07 74,29 -0,03% 0,58% 1.501.742
23/08/2018 74,17 74,88 74,14 74,31 -0,13% 0,99% 1.687.967
22/08/2018 73,78 74,65 73,66 74,41 +0,61% 1,35% 1.975.362
21/08/2018 72,90 74,57 72,88 73,97 +1,28% 2,32% 2.556.225
20/08/2018 73,19 73,45 72,82 73,03 +0,18% 0,86% 1.624.145
17/08/2018 72,33 73,15 72,31 72,90 +0,88% 1,17% 2.184.417
16/08/2018 71,30 72,27 70,93 72,27 +0,69% 1,87% 2.603.642
15/08/2018 72,45 73,05 71,46 71,77 -0,95% 2,20% 2.996.202
14/08/2018 73,16 73,47 72,27 72,45 -0,87% 1,64% 2.507.384
13/08/2018 72,75 73,63 72,42 73,09 -0,30% 1,65% 2.817.226
10/08/2018 72,80 74,24 72,57 73,31 +0,75% 2,30% 3.884.040
09/08/2018 73,00 73,25 72,51 72,76 -1,07% 1,01% 1.986.417
08/08/2018 72,93 73,63 72,73 73,55 -0,01% 1,23% 1.955.026
07/08/2018 73,10 74,09 73,02 73,56 +0,33% 1,46% 2.132.201